Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Where Were the Women? Gender Parity in Clinical Trials.

× No keyword cloud information.

10 in total

1. Filling the Regulatory Gap: Potential Role of Institutional Review Boards in Promoting Consideration of Sex as a Biological Variable.

Authors: Korrina A Duffy; Tracy A Ziolek; C Neill Epperson
Journal: J Womens Health (Larchmt) Date: 2020-04-08 Impact factor: 2.681

2. Tenofovir Alafenamide for HIV Preexposure Prophylaxis: What Can We DISCOVER About Its True Value?

Authors: Douglas S Krakower; Demetre C Daskalakis; Judith Feinberg; Julia L Marcus
Journal: Ann Intern Med Date: 2020-01-14 Impact factor: 25.391

Review 3. Where are the pregnant and breastfeeding women in new pre-exposure prophylaxis trials? The imperative to overcome the evidence gap.

Authors: Dvora L Joseph Davey; Linda-Gail Bekker; Elizabeth A Bukusi; Benjamin H Chi; Sinead Delany-Moretlwe; Ameena Goga; Anne Drapkin Lyerly; Nyaradzo M Mgodi; Nelly Mugo; Landon Myer; Lisa M Noguchi; Lynda Stranix-Chibanda; Catherine Slack; Jillian Pintye
Journal: Lancet HIV Date: 2022-01-25 Impact factor: 16.070

Review 4. Contribution of Sex Differences to HIV Immunology, Pathogenesis, and Cure Approaches.

Authors: Jose A Moran; Shireen R Turner; Matthew D Marsden
Journal: Front Immunol Date: 2022-05-25 Impact factor: 8.786

Review 5. A Bayesian averted infection framework for PrEP trials with low numbers of HIV infections: application to the results of the DISCOVER trial.

Authors: David V Glidden; Oliver T Stirrup; David T Dunn
Journal: Lancet HIV Date: 2020-11 Impact factor: 12.767

Where Were the Women? Gender Parity in Clinical Trials.

1. Filling the Regulatory Gap: Potential Role of Institutional Review Boards in Promoting Consideration of Sex as a Biological Variable.

2. Tenofovir Alafenamide for HIV Preexposure Prophylaxis: What Can We DISCOVER About Its True Value?

Review 3. Where are the pregnant and breastfeeding women in new pre-exposure prophylaxis trials? The imperative to overcome the evidence gap.

Review 4. Contribution of Sex Differences to HIV Immunology, Pathogenesis, and Cure Approaches.

Review 5. A Bayesian averted infection framework for PrEP trials with low numbers of HIV infections: application to the results of the DISCOVER trial.

Review 6. Hidden in plain sight: sex and gender in global pandemics.

7. Towards equity for people who inject drugs in HIV prevention drug trials.

8. Influence of Sex on Urinary Organic Acids: A Cross-Sectional Study in Children.

9. Making pharmaceutical research and regulation work for women.

10. A 10-year longitudinal evaluation of science policy interventions to promote sex and gender in health research.